Due to preclinical evidence indicating H3R activation inhibits glutamatergic signaling, we hypothesized H3R availability would negatively correlate with markers of glutamate in the anterior cingulate cortex (ACC) and striatum for both patients with schizophrenia and healthy volunteers. Here, HRH3 is linked to schizophrenia.